Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan

• Main Authors: Hitoshi Tajiri (Author), Katsuhiro Arai (Author), Seiichi Kagimoto (Author), Reiko Kunisaki (Author), Nobuyuki Hida (Author), Noriko Sato (Author), Hiroshi Yamada (Author), Mieko Nagano (Author), Yutaka Susuta (Author), Kunihiko Ozaki (Author), Kazuoki Kondo (Author), Toshifumi Hibi (Author)
• Format: Book
• Published: BMC, 2019-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Pediatric ulcerative colitis (UC) is typically more extensive and has a more active disease course than adult UC, and requires early treatment augmentation to achieve and maintain disease remission. The present study aimed to investigate the efficacy, safety, and pharmacokinetic...